Learning Objectives:

  1. Become aware of how SGLT2 inhibitors work to reduce CV mortality.
  2. Become aware of how SGLT2 inhibitors may slow kidney disease progression.
  3. Become aware of adverse events from chronic use.
Session date: 
Monday, September 25, 2017 - 5:00pm to 6:00pm
Speaker Name: 
George L. Bakris, M.D.
Location: 
UCMC M-170
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.